Seong-Heon Wie

Seong-Heon Wie

Auto-generated profile, based on publicly available information

Seong-Heon Wie

Division of Infectious Diseases, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
CKCheol-In Kang
Cheol-In Kang
JKJieun Kim
Jieun Kim
DPDae Won Park
Dae Won Park
BKBaek-Nam Kim
Baek-Nam Kim
UHU-Syn Ha
U-Syn Ha
SWSeong-Heon Wie
Seong-Heon Wie
Kang CI, et al. Infect Chemother. 2018 Mar;50(1):67-100. https://doi.org/10.3947/ic.2018.50.1.67

1 January 2015 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
SWSeong-Heon Wie
Seong-Heon Wie
Wie SH. Korean J Intern Med. 2015 Mar;30(2):167-169. http://dx.doi.org/10.3904/kjim.2015.30.2.167

1 January 2014 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MSMi-Ran Seo
Mi-Ran Seo
SKSeong-Jong Kim
Seong-Jong Kim
YKYeonjae Kim
Yeonjae Kim
JKJieun Kim
Jieun Kim
TCTae Yeal Choi
Tae Yeal Choi
HPHyunjoo Pai
Hyunjoo Pai
Seo MR, et al. J Korean Med Sci. 2014 Aug;29(8):1178-1181. https://doi.org/10.3346/jkms.2014.29.8.1178

1 January 2014 in The Korean Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
WCWon Suk Choi
Won Suk Choi
JBJi Hyeon Baek
Ji Hyeon Baek
YSYu Bin Seo
Yu Bin Seo
SKSae Yoon Kee
Sae Yoon Kee
HJHye Won Jeong
Hye Won Jeong
TKTransgovernmental Enterprise For Pandemic Influenza In Korea
Transgovernmental Enterprise For Pandemic Influenza In Korea
Choi WS, et al. Korean J Intern Med. 2014 Jan;29(1):132-147. http://dx.doi.org/10.3904/kjim.2014.29.1.132

1 January 2019 in Infection & Chemotherapy
Verified
Journal Article
Open access
MKMi-Hee Kim
Mi-Hee Kim
SKSi-Hyun Kim
Si-Hyun Kim
JCJung-Hyun Choi
Jung-Hyun Choi
SWSeong-Heon Wie
Seong-Heon Wie
Scrub typhus, a mite-borne disease caused by bites of Orientia tsutsugamushi-infected chiggers, is endemic in Asia-Pacific countries. In Korea, it is a seasonal disease prevalent in autumn and one of the important causes of acute undifferentiated febrile illness. The purpose of this study was to identify the risk factors for the prediction of the severe clinical course of scrub typhus and to investigate the differences in the clinical and laboratory findings of hospitalized elderly and non-elderly patients with scrub typhus. This study retrospectively reviewed the medical records of patients diagnosed with scrub typhus. A total of 710 patients were enrolled and 43.9% of them were elderly patients. The number of patients with complicated scrub typhus was 168 (23.7%) and the most common complication of severe scrub typhus was hepatic dysfunction (10.7%) followed by pneumonia (7.2%), acute kidney injury (4.9%) and shock (2.4%). Blood urea nitrogen ≥20 mg/dL, adenosine deaminase (ADA) ≥100 IU/L, pulmonary edema or pleural effusion, lactate dehydrogenase ≥500 U/L, alkaline phosphatase ≥400 IU/L, ferritin ≥500 ng/mL and absence of skin rash were independently associated with severe scrub typhus. There was no significant difference in the incidence of complicated scrub typhus between elderly and non-elderly patients. Absence of skin rash, pulmonary edema, pleural effusion, serum creatinine ≥1.5 mg/dL, total bilirubin ≥1.5 mg/dL, ADA ≥100 IU/L and ferritin ≥500 ng/mL were significantly associated with a longer hospitalization (≥10 days). The several independent predictors of complicated scrub typhus were identified in this study. Absence of skin rash, the increased levels of serum ADA and ferritin were identified as the predictors of complicated scrub typhus, which were also associated with a prolonged hospitalization.

6 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJoon Young Song
Joon Young Song
JNJi Yun Noh
Ji Yun Noh
JLJin Soo Lee
Jin Soo Lee
SWSeong-Heon Wie
Seong-Heon Wie
YKYoung Keun Kim
Young Keun Kim
WKWoo Joo Kim
Woo Joo Kim
Influenza and pneumonia are leading causes of morbidity and mortality among the elderly. Although vaccination is a main strategy to prevent these infectious diseases, concerns remain with respect to vaccine effectiveness. During three influenza seasons (2014–2015, 2015–2016 and 2016–2017), we evaluated the effectiveness of the influenza and pneumococcal vaccines against pneumonia and acute exacerbation of cardiopulmonary diseases among the elderly aged ≥65 years with influenza-like illness (ILI). Demographic and clinical data were collected prospectively. Among 2,119 enrolled cases, 1,302 (61.4%) and 871 (41.1%) received the influenza vaccine and 23-valent pneumococcal polysaccharide vaccine (PPV23), respectively. During an A/H3N2-dominant season with poor influenza vaccine effectiveness (2014–2015 season), neither the influenza vaccine nor PPV23 showed significant effectiveness against pneumonia or acute exacerbation of cardiopulmonary diseases. During seasons with good influenza vaccine effectiveness (2015–2016 and 2016–2017 seasons), the influenza vaccine was effective in preventing pneumonia, but PPV23 was not. In particular, the influenza vaccine was effective in preventing acute exacerbation of heart diseases (75.0%) during the A/H1N1-dominant 2015–2016 season. The influenza vaccine was effective in preventing pneumonia only during vaccine-matched seasons with good effectiveness against circulating influenza viruses. In addition, the influenza vaccine was cardio-protective during a vaccine-matched A/H1N1-dominant season.